Research theme for competitive and other funds (2):
2018 - 2022 Liver cancer research in non-alcoholic fatty liver disease
2017 - 2020 Evaluation of the role of gut-microbiota in NASH-associated HCC pathogenesis
Papers (176):
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, et al. Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH. European radiology. 2024
Yuji Ogawa, Wataru Tomeno, Yasushi Imamura, Masaru Baba, Takato Ueno, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Takaomi Kessoku, Yasushi Honda, et al. Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Suguru Kurokawa, Takuro Kobori, Masato Yoneda, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima, Kikuko Hotta. Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma. BMC gastroenterology. 2024. 24. 1. 57-57
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, Anna Ozaki, Yuki Kasai, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Yuji Ogawa, Kento Imajo, et al. Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease. Hepatology communications. 2023. 7. 11
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Nobuyoshi Kawamura, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda, Satoru Saito, Atsushi Nakajima. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of gastroenterology. 2023
尾崎杏奈, 結束貴臣, 結束貴臣, 葛西祐樹, 竹田雄馬, 大久保直紀, 岩城慶大, 小林貴, 吉原努, 吉原努, et al. Elobixibat effectively relieves chronic constipation in cancer patients, regardless of food intake amount. 日本消化管学会雑誌. 2021. 5. Supplement
Takaomi Kessoku, Takashi Kobayashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Yuji Ogawa, Kento Imajo, Shingo Kato, Takuma Higurashi, et al. EFFICACY AND SAFETY OF LUBIPROSTONE TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE WITH ADVANCED FIBROSIS: A POST-HOC ANALYSIS OF THE LUBIPRONE RANDOMIZED TRIAL. HEPATOLOGY. 2020. 72. 1017-1017
Kento Imajo, Yasushi Honda, Masato Yoneda, Satoru Saito, Atsushi Nakajima. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Journal of Medical Ultrasonics. 2020. 47. 4. 535-548
Yasushi Honda, Masato Yoneda, Kento Imajo, Atsushi Nakajima. Elastography techniques for the assessment of liver fibrosis in non-alcoholic fatty liver disease. International Journal of Molecular Sciences. 2020. 21. 11. 1-14